Overview
Basic information
Litigation
Active legal matters
Material Events
8-K disclosures
SEC Filings
Key regulatory docs
Insider Transactions
Ownership changes
In Litigation
0
Settlement
1
Closed
Total Settlement
$9.75M
Critical Governance & Disclosure
Board, Voting & Shareholder Rights
Capital Structure & Financial Risk
Disclosure & Communications
Current report
2026-10-30
2026-09-01
2026-08-28
2026-08-25
2026-08-24
No Insider Transactions found for BioXcel Therapeutics, Inc.
TOP